Page 44 - Journal of Special Operations Medicine - Fall 2014
P. 44

casualty care.  J Trauma Acute Care  Surg. 2012;73:   resuscitation strategies in a large animal model of com-
               S431– S437.                                        bines insults. Shock. 2012;38:49–56.
          119.  Frith D, Davenport R, Brohi K. Acute traumatic coagu-  135.  Lissauer M, Chi A, Kramer M, et al. Association of 6%
               lopathy. Curr Opin Anaesthesiol. 2012;25:229–234.  hetastarch resuscitation with adverse outcomes in criti-
          120.  Mitra B, Cameron P, Mori A, Fitzgerald M. Acute co-  cally ill trauma patients. Am J Surg. 2011. Epub ahead
               agulopathy and early deaths post major trauma. Injury.   of print.
               2012;43:22–25.                                136.  FDA  Safety  Communication.  Boxed  warning  on in-
          121.  Imam AM, Jin G, Duggan M, et al. Early treatment with   creased mortality and severe renal injury, and additional
               lyophilized plasma protects the brain in a large animal   warning on risk of bleeding, for use of hydroxyethyl
               model of combined traumatic brain injury and hemor-  starch solutions in some settings. http://www.fda.gov
               rhagic shock. J Trauma Acute Care Surg. 2013;75:976–   /biologicsbloodvaccines/safetyavailability/ucm358271
               983.                                               .htm.
          122.  Hwabejire JO, Imam AM, Liu B, et al. Differential effects   137.  Gan TJ, Bennett-Guerrero E, Phillips-Bute B, et al. Hex-
               of fresh frozen plasma and normal saline on secondary   tend,  a physiologically  balanced  plasma  expander  for
               brain damage in a large animal model of polytrauma,   large volume use in major surgery: a randomized phase
               hemorrhage, and traumatic brain injury. J Trauma Acute   III clinical trial. Anesth Analg. 1999;88:992–998.
               Care Surg. 2013;75:968–975.                   138.  COL Kirby Gross et al, personal communication, 2013.
          123.  Lee L, Moore E, Hansen K, et al. It’s not your grandfa-  139.  Ogilvie M, Ryan M, Proctor K. Hetastarch during initial
               ther’s field plasma. Acute Care Surg. 2013;75:369–375.  resuscitation for trauma. J Trauma. 2011;70:S19–S21.
          124.  Lee T, Watson K, Fabricant L, et al. Hyperosmolar recon-  140.  James MFM, Michell WL, Joubert IA, et al. Resuscita-
               stituted lyophilized plasma is an effective low-volume he-  tion with hydroxyethyl starch improves renal function
               mostatic resuscitation fluid for trauma. J Trauma. 2013;   and lactate clearance in penetrating trauma in a random-
               75:369–375.                                        ized controlled study: the FIRST trial (Fluids in Resusci-
          125.  Lemcke J, Al-Zain F, Brelie CvD, Meier U. The influence   tation of Severe Trauma). Br J Anaesth. 2011. Published
               of coagulopathy on outcome after traumatic subdural   online 19 August 2011.
               hematoma: a retrospective single-center analysis of 319   141.  Myburgh JA, Finfer S, Bellomo R, et al. Hydroxyethyl
               patients. Blood Coagul Fibrinolysis. 2014;353–359.  starch for fluid resuscitation in intensive care. N Engl J
          126.  Annane D, Siami S, Jaber S, et al; for the CRISTAL In-  Med. 2012;367:1901–1911.
               vestigators. Effects of Fluid Resuscitation With Colloids   142.  Rasmussen KC, Johansson PI, Hojskov M, et al. Hy-
               versus Crystalloids on Mortality in Critically Ill Patients   droxyethyl starch reduces coagulation competence and
               Presenting With Hypovolemic  Shock. The CRISTAL    increases  blood loss during  major surgery.  Ann Surg.
               Randomized Trial. JAMA. 2013. Published online 9 Oc-  2013. Epub ahead of print.
               tober 2013.                                   143.  Van der Linden P, James M, Mythen M, Weiskopf RB.
          127.  Marino PL. Colloid and crystalloid resuscitation. In The   Safety of modern starches used during surgery. Anesth
               ICU Book, 3rd ed. Philadelphia, PA: Lippincott Williams   Analg. 2013;116:35–48.
               & Wilkins; 2007:233–253.                      144.  Gandhi SD, Weiskopf RB, Junghein C, et al. Volume re-
          128.  Pape A, Kutschker S, Kertscho H, et al. The choice of the   placement therapy during major orthopedic surgery us-
               intravenous fluid influences the tolerance of acute nor-  ing Voluven (hydroxyethyl starch 130/0.4 or hetastarch.
               movolemic anemia in anesthetized domestic pigs.  Crit   Anesthesiology. 2007;106:1120–1127.
               Care. 2012. Epub ahead of print.              145.  Myburgh J, Cooper DJ, Finfer S, et al. Saline or albumin
          129.  Gillies  M,  Habicher  M,  Jhanji  S,  et  al.  Incidence  of   for fluid resuscitation in patients with traumatic brain
               postoperative death and acute kidney injury associated   injury. N Engl J Med. 2007;357:874–884.
               with i.v. hydroxyethyl starch use: systematic review    146.  Finfer S. Reappraising the role of albumin for resuscita-
               and meta-analysis. Br J Anaesth. 2013. Epub ahead of   tion. Curr Opin Crit Care. 2013;19:315–320.
               print.                                        147.  Myburgh JA, Finfer S. Albumin is a blood product too—
          130.  Perel P, Roberts I, Ker K. Colloids versus crystalloids for   is it safe  for all patients?  Crit Care  Resusc. 2009;11:
               fluid resuscitation in critically ill patients. Cochrane Rev.   67–70.
               2013(3).                                      148.  Roberts I, Blackhall K, Alderson P, et al. Human albumin
          131.  Zarychanski R, Abou-Setta A, Turgeon A, et al. Asso-  solution for resuscitation and volume expansion in criti-
               ciation of hydroxyethyl starch admission with mortality   cally ill patients. Cochrane Database Syst Rev 2011;Nov 9.
               and acute kidney injury in critically ill patients requiring   149.  Kwan I, Bunn F, Roberts I. Timing and volume of fluid
               volume resuscitation. JAMA. 2013;309:678–688.      administration for patients with bleeding—a review.
          132.  Ryan M, Ogilvie M, Pereira B, et al. Effect of hetastarch     Cochrane Rep. 2001(1):CD002245.
               bolus in trauma patients requiring emergency surgery.    150.  Traverso LW, Lee WP, Langford MJ. Fluid resuscitation
               J Spec Oper Med. 2012;12:57–67.                    after an otherwise fatal hemorrhage. I. Crystalloid solu-
          133.  Balogh Z, McKinley BA, Holcomb JB. Both primary   tions. J Trauma. 1986;26:168–175.
               and secondary abdominal compartment syndrome can   151.  Hu S, Bai XD, Liu XQ, et al. Pyruvate Ringer’s solution
               be predicted early and are harbingers of multiple organ   corrects lactic acidosis and prolongs survival during hem-
               failure. J Trauma. 2003;54:848–859.                orrhagic shock in rats. J Emerg Med. 2013;45:885–893.
          134.  Jin G, Duggan M, Demoya M, et al. Traumatic brain   152.  Schreiber M. The use of normal saline for resuscitation
               injury and hemorrhagic shock: evaluation of different   in trauma. J Trauma. 2011;70:S13–S14.



          36                                       Journal of Special Operations Medicine  Volume 14, Edition 3/Fall 2014
   39   40   41   42   43   44   45   46   47   48   49